Cytokinetics (CYTK) Regains Nasdaq Listing Compliance
Get Alerts CYTK Hot Sheet
Join SI Premium – FREE
On January 24, 2013, Cytokinetics, Incorporated (Nasdaq: CYTK) received a notice from The Nasdaq Stock Market ("Nasdaq") confirming that for the last 10 consecutive business days, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1).
As previously reported, the Company received notice from Nasdaq on June 18, 2012 that the Company’s common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. On December 18, 2012, the Company transferred its listing to the Nasdaq Capital Market and Nasdaq provided the Company until June 17, 2013 to achieve compliance with the Listing Rule 5450(a)(1) requirement.
Nasdaq has informed the Company that this matter is now closed.
As previously reported, the Company received notice from Nasdaq on June 18, 2012 that the Company’s common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. On December 18, 2012, the Company transferred its listing to the Nasdaq Capital Market and Nasdaq provided the Company until June 17, 2013 to achieve compliance with the Listing Rule 5450(a)(1) requirement.
Nasdaq has informed the Company that this matter is now closed.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cytokinetics (CYTK) option IV amid wide price movement
- National Storage Affiliates Trust (NSA) Appoints Melissa Cameron as Chief Marketing Officer
- Cytokinetics (CYTK) call put ratio 1.6 calls to 1 put as share price up 4.8%
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!